Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sreeja Parameswaran

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|August 6, 2025
Systematic investigation reveals extensive Epstein-Barr virus transcriptional regulation of the human genomePhillip J Dexheimer, Matthew R Hass, Lee E Edsall, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Comparison of PU.1 genomic binding across immune cells reveals cell type-specific roles in autoimmune diseaseDavid A Lewis, Molly S Shook, Lucinda P Lawson, et al.
BMC Genomics|March 13, 2024
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genomeKenyatta C M F Viel, Sreeja Parameswaran, Omer A Donmez, et al.
Elife|September 10, 2025
Human cytomegalovirus infection coopts chromatin organization to diminish TEAD1 transcription factor activityKhund Sayeed, Sreeja Parameswaran, Matthew J Beucler, et al.
BMC Medicine|July 18, 2019
GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE NetworkBahram Namjou, Todd Lingren, Yongbo Huang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease riskValeriya Malysheva, Helen Ray-Jones, Nora Lakes, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal modelsJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Cell|April 9, 2021
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammationJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunitySamuel J Virolainen, Kathryn Creighton, Maryam Dashtiahangar, et al.
Annals of the Rheumatic Diseases|December 4, 2020
Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosusXianyong Yin, Kwangwoo Kim, Hiroyuki Suetsugu, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|August 6, 2025
Systematic investigation reveals extensive Epstein-Barr virus transcriptional regulation of the human genomePhillip J Dexheimer, Matthew R Hass, Lee E Edsall, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Comparison of PU.1 genomic binding across immune cells reveals cell type-specific roles in autoimmune diseaseDavid A Lewis, Molly S Shook, Lucinda P Lawson, et al.
BMC Genomics|March 13, 2024
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genomeKenyatta C M F Viel, Sreeja Parameswaran, Omer A Donmez, et al.
Elife|September 10, 2025
Human cytomegalovirus infection coopts chromatin organization to diminish TEAD1 transcription factor activityKhund Sayeed, Sreeja Parameswaran, Matthew J Beucler, et al.
BMC Medicine|July 18, 2019
GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE NetworkBahram Namjou, Todd Lingren, Yongbo Huang, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease riskValeriya Malysheva, Helen Ray-Jones, Nora Lakes, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal modelsJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Cell|April 9, 2021
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammationJessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunitySamuel J Virolainen, Kathryn Creighton, Maryam Dashtiahangar, et al.
Annals of the Rheumatic Diseases|December 4, 2020
Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosusXianyong Yin, Kwangwoo Kim, Hiroyuki Suetsugu, et al.
Pageof 6